Latest Alligator Bioscience News & Updates

See the latest news and media coverage for Alligator. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Alligator Bioscience (Alligator)

Clinical-stage biotechnology company developing tumor-directed cancer immunotherapies

alligatorbioscience.se
Headquarters
Lund, Sweden
Founded year
2001
Company type
Public company
Number of employees
25–50
Industry
Pharmaceuticals

Last updated

Latest news about Alligator Bioscience (Alligator)

In short: Alligator underwent a strategic realignment, discontinuing independent development of mitazalimab to focus on its HLX22 interests.

Company announcements

Alligator

Alligator discontinues mitazalimab development and announces rights issue

The company refocuses on HLX22 project and raises approximately SEK 125.6 million via rights issue and bridge loans.

Unlock all announcements with a

Media coverage

Sina Finance

Core pipeline cut, Biotech plunges 74%

Alligator Bioscience was founded in 2001 and is headquartered in Lund, Sweden, focusing on the development of tumor immunology antibody drugs targeting the CD40 receptor. Its core pipeline, mitazalimab, is a CD40 agonist monoclonal antibody that demonstrated significant efficacy in the Phase II clinical trial OPTIMIZE-1 for first-line metastatic pancreatic cancer, and was once positioned by the company as a key asset about to enter Phase III development...

Unlock all articles with a

Never miss news about Alligator

Track Alligator and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Alligator competitors & trending companies

Browse news for competitors to Alligator and other trending companies.